| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0173-0876-10 | 0173-0876 | HUMAN PRESCRIPTION DRUG | Arnuity Ellipta | fluticasone furoate | POWDER | RESPIRATORY (INHALATION) | 20140820 | N/A | NDA | NDA205625 | GlaxoSmithKline LLC | FLUTICASONE FUROATE | 200 ug/1 | 1 INHALER in 1 CARTON (0173-0876-10) / 30 POWDER in 1 INHALER |
| 0173-0876-14 | 0173-0876 | HUMAN PRESCRIPTION DRUG | Arnuity Ellipta | fluticasone furoate | POWDER | RESPIRATORY (INHALATION) | 20140820 | N/A | NDA | NDA205625 | GlaxoSmithKline LLC | FLUTICASONE FUROATE | 200 ug/1 | 1 INHALER in 1 CARTON (0173-0876-14) / 14 POWDER in 1 INHALER |
| 0173-0874-10 | 0173-0874 | HUMAN PRESCRIPTION DRUG | Arnuity Ellipta | fluticasone furoate | POWDER | RESPIRATORY (INHALATION) | 20140820 | N/A | NDA | NDA205625 | GlaxoSmithKline LLC | FLUTICASONE FUROATE | 100 ug/1 | 1 INHALER in 1 CARTON (0173-0874-10) / 30 POWDER in 1 INHALER |
| 0173-0874-14 | 0173-0874 | HUMAN PRESCRIPTION DRUG | Arnuity Ellipta | fluticasone furoate | POWDER | RESPIRATORY (INHALATION) | 20140820 | N/A | NDA | NDA205625 | GlaxoSmithKline LLC | FLUTICASONE FUROATE | 100 ug/1 | 1 INHALER in 1 CARTON (0173-0874-14) / 14 POWDER in 1 INHALER |
| 0173-0888-10 | 0173-0888 | HUMAN PRESCRIPTION DRUG | Arnuity Ellipta | fluticasone furoate | POWDER | RESPIRATORY (INHALATION) | 20180517 | N/A | NDA | NDA205625 | GlaxoSmithKline LLC | FLUTICASONE FUROATE | 50 ug/1 | 1 INHALER in 1 CARTON (0173-0888-10) / 30 POWDER in 1 INHALER |